Colgate-Palmolive Company vs Quest Diagnostics Inc — how do they compare? Colgate-Palmolive Company trades at $92.31 (market cap $73.59B), while Quest Diagnostics Inc trades at $237.5 (market cap $26.21B). The key difference: Colgate-Palmolive Company is far larger — about 2.8× Quest Diagnostics Inc's market cap, and Colgate-Palmolive Company pays the higher dividend (2.3%). Which is the better fit depends on your goals.
| CL | DGX | |
|---|---|---|
Market Cap | $73.59B | $26.21B |
Sector | Consumer Staples | Health |
52-Week High | $99.14 | $238.50 |
52-Week Low | $74.98 | $173.49 |
Enterprise Value | $80.07B | $31.97B |
Dividend Yield | 2.3% | 1.45% |
Trailing returns across standard periods
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →